The IPOList

Blogs

Home

/

SGLTL

Standard Glass Lining Technology

Standard Glass Lining Technology

SGLTL

📅

Bidding Dates

6 Jan 2025 - 8 Jan 2025

💰

Price Range

₹133 - ₹140

🔢

Minimum Investment

₹14,980

📊

Issue Size

410Cr

💰

Latest GMP

₹80 (57.14%)

IPO Timeline

1

Issue open date

6 Jan 2025

2

Issue close date

8 Jan 2025

3

UPI mandate deadline

8 Jan 2025

4

Allotment finalization

9 Jan 2025

5

Refund initiation

10 Jan 2025

6

Share credit

10 Jan 2025

7

Listing date

13 Jan 2025

8

Mandate end date

23 Jan 2025

9

Lock-in end date for anchor investors (50%)

8 Feb 2025

10

Lock-in end date for anchor investors (remaining)

9 Apr 2025

About the Company

Incorporated in September 2012, Standard Glass Lining Technology Limited manufactures engineering equipment for the pharmaceutical and chemical sectors. The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures. Its product portfolio includes Reaction Systems, Storage, Separation and Drying Systems, and Plant Engineering. The company operates eight manufacturing units in Hyderabad and has sales offices in various locations across India. Notable clients include Aurobindo Pharma, Cadila Pharmaceuticals, and Laurus Labs.

Strengths

  1. Top five specialized engineering equipment manufacturers for India’s pharmaceutical and chemical sectors.
  2. Leading manufacturer of glass-lined, stainless steel, and nickel alloy-based equipment in India.
  3. Custom solutions for pharmaceutical, chemical, food, and beverage industries.
  4. Supplied over 11,000 products in the last decade, meeting diverse sector needs.
  5. In-house manufacturing of stainless steel glass-lined reactors, up to 10KL capacity.
  6. Active partnerships with HHV Pumps and GL Hakko to strengthen product offerings and market position.
  7. Equipped with cutting-edge CNC plasma, laser cutting, and welding systems.

Risks

  1. The company has guaranteed subsidiary loans, and defaults may incur costs that impact profitability.
  2. Heavy dependence on pharmaceutical and chemical sectors.
  3. Risks from under-utilization of manufacturing capacity.
  4. Vulnerability to delays or defaults in customer payments.
  5. Exposure to raw material cost fluctuations.
  6. Limited ability to pass on raw material cost increases.
  7. Dependence on Telangana facilities, subject to risks from disasters and political changes.

Grey Market Premium Trend

Made with ❤️ by Harsh Goel
Disclaimer: The content provided on theipolist.in is for educational and informational purposes only. We are not SEBI-registered advisors and are not involved in any grey market trades. Please consult with a registered financial advisor before making any investment decisions.